Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets.

Napoletano C, Ruscito I, Bellati F, Zizzari IG, Rahimi H, Gasparri ML, Antonilli M, Panici PB, Rughetti A, Nuti M.

J Clin Med. 2019 Mar 18;8(3). pii: E380. doi: 10.3390/jcm8030380.

2.

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial.

Antonilli M, Rahimi H, Visconti V, Napoletano C, Ruscito I, Zizzari IG, Caponnetto S, Barchiesi G, Iadarola R, Pierelli L, Rughetti A, Bellati F, Panici PB, Nuti M.

Int J Oncol. 2016 Apr;48(4):1369-78. doi: 10.3892/ijo.2016.3386. Epub 2016 Feb 8.

3.

Threatened abortion and late-pregnancy complications: a case-control study and review of literature.

Petriglia G, Palaia I, Musella A, Marchetti C, Antonilli M, Brunelli R, Ostuni R, Benedetti Panici P.

Minerva Ginecol. 2015 Dec;67(6):491-7. Epub 2015 Feb 5. Review.

PMID:
25668506
4.

Surgical treatment of an isolated omental cervical cancer recurrence: report of a case and review of the literature.

Gasparri ML, Bellati F, Pernice M, Di Donato V, Morano G, Marchetti C, Donfrancesco C, Antonilli M, Benedetti Panici P.

Tumori. 2014 Mar-Apr;100(2):e52-4. doi: 10.1700/1491.16437. Review.

PMID:
24852877
5.

Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing.

Rughetti A, Rahimi H, Belleudi F, Napoletano C, Battisti F, Zizzari IG, Antonilli M, Bellati F, Wandall HH, Benedetti Panici P, Burchell JM, Torrisi MR, Nuti M.

Cancer Immunol Res. 2014 Feb;2(2):177-86. doi: 10.1158/2326-6066.CIR-13-0112-T. Epub 2013 Oct 28.

6.

Effects of unilateral ovariectomy on female fertility outcome.

Bellati F, Ruscito I, Gasparri ML, Antonilli M, Pernice M, Vallone C, Morano G, Chirletti P, Berloco PB, Panici PB.

Arch Gynecol Obstet. 2014 Aug;290(2):349-53. doi: 10.1007/s00404-014-3194-8. Epub 2014 Mar 11.

PMID:
24615568
7.

Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells.

Paroli M, Bellati F, Videtta M, Focaccetti C, Mancone C, Donato T, Antonilli M, Perniola G, Accapezzato D, Napoletano C, Nuti M, Bartolazzi A, Panici PB, Tripodi M, Palombo F, Barnaba V.

Int J Cancer. 2014 Apr 15;134(8):1823-34. doi: 10.1002/ijc.28515. Epub 2013 Oct 22. Erratum in: Int J Cancer. 2014 Jul 15;135(2):E1.

8.

Past, present and future strategies of immunotherapy in gynecological malignancies.

Bellati F, Napoletano C, Ruscito I, Visconti V, Antonilli M, Gasparri ML, Zizzari IG, Rahimi H, Palaia I, Rughetti A, Benedetti Panici P, Nuti M.

Curr Mol Med. 2013 May;13(4):648-69.

PMID:
22934850
9.

Laparoscopically guided minilaparotomy: a minimally invasive approach for the treatment of gynaecologic diseases in morbidly obese patients.

Benedetti Panici P, Perniola G, Pernice M, Antonilli M, Achilli C, Di Donato V, Bellati F.

Eur J Obstet Gynecol Reprod Biol. 2012 Feb;160(2):210-4. doi: 10.1016/j.ejogrb.2011.11.010. Epub 2011 Dec 2.

PMID:
22136884
10.

HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.

Zizzari IG, Veglia F, Taurino F, Rahimi H, Quaglino E, Belleudi F, Riccardo F, Antonilli M, Napoletano C, Bellati F, Benedetti-Panici P, Torrisi MR, Frati L, Nuti M, Rughetti A.

J Mol Med (Berl). 2011 Dec;89(12):1231-40. doi: 10.1007/s00109-011-0794-7. Epub 2011 Aug 16.

11.

Let's think twice before abandoning fibrillar oxidized regenerated cellulose.

Perniola G, Antonilli M, Gasparri ML.

Ann Surg Oncol. 2011 Dec;18 Suppl 3:S292-3; author reply S294. doi: 10.1245/s10434-010-1520-3. Epub 2011 Jan 7. No abstract available.

PMID:
21213055
12.

Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review.

Bellati F, Napoletano C, Ruscito I, Pastore M, Pernice M, Antonilli M, Nuti M, Benedetti Panici P.

Invest New Drugs. 2010 Dec;28(6):887-94. doi: 10.1007/s10637-009-9351-4. Epub 2009 Nov 24. Review.

PMID:
19936983
13.

HPV induced triple neoplasms: a case report.

Visconti V, Antonilli M, Bellati F, Napoletano C, French D, Benedetti Panici P, Nuti M.

Am J Obstet Gynecol. 2009 Aug;201(2):e9-e12. doi: 10.1016/j.ajog.2009.05.008.

PMID:
19646562
14.

Immunology of gynecologic neoplasms: analysis of the prognostic significance of the immune status.

Bellati F, Visconti V, Napoletano C, Antonilli M, Frati L, Panici PB, Nuti M.

Curr Cancer Drug Targets. 2009 Jun;9(4):541-65. Review.

PMID:
19519321
15.

Neoadjuvant chemotherapy followed by radical surgery in patients affected by vaginal carcinoma.

Benedetti Panici P, Bellati F, Plotti F, Di Donato V, Antonilli M, Perniola G, Manci N, Muzii L, Angioli R.

Gynecol Oncol. 2008 Nov;111(2):307-11. doi: 10.1016/j.ygyno.2008.07.005. Epub 2008 Aug 16.

PMID:
18708243
16.

An investigation on calcium (II) oxalate as solubility and universal standard.

Antonilli M, Bottari E, Festa MR, Gentile L.

Ann Chim. 2007 Oct;97(10):1085-96.

PMID:
18154002
17.

Taurocholate and taurodeoxycholate: gel formation and protonation constants.

Antonilli M, Bottari E, Festa MR.

Ann Chim. 2007 Jan-Feb;97(1-2):39-48.

PMID:
17822262
18.

Ratios between content of fatty acids as markers for mixture of cow and goat milk.

Antonilli M, Bottari E, Festa MR.

Ann Chim. 2005 Jul-Aug;95(7-8):501-14.

PMID:
16235784

Supplemental Content

Loading ...
Support Center